ADVB - Advanced Biomed Inc. Common Stock
Advanced Biomed Inc. , an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. Its devices include A+Pre, a fully automated sample preparation system that enables pre-concentration of diluted blood samples; AC-1000, a rare cell device to solve the problem of detection of hypercoagulable state samples of tumor patients; A+SCDrop, a circulating tumor cells (CTCs) single-cell capture device; and A+CellScan, an analyzer with an immunostaining chip for immunostaining/analysis of the AC-1000 product.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Market Cap
- $5.4M
- Beta
- 0.57
- 52-Week Range
- 3.61-21.8
- CEO
- Yi Lu
- Employees
- 40
- IPO Date
- Mar 6, 2025
- Exchange
- NASDAQ
ADVB Options Snapshot
Options pricing data for ADVB is refreshed daily after the close. When listed contracts exist, this page surfaces the latest at-the-money implied volatility, max pain strike, dealer gamma exposure (GEX), and 25-delta skew. Listed contracts and live snapshots appear once the options chain has been published by the exchange for the most recent session.
What This Page Covers
The ADVB overview links into per-metric analysis views: max pain, gamma exposure, volatility skew, expected move, options chain, open interest history, and aggregate Greeks. Microstructure data is available on short interest, short volume, fail-to-deliver, and market structure. Corporate data is on fundamentals, earnings, analyst ratings, and insider trading.
Frequently asked ADVB overview questions
- What is ADVB?
- ADVB is the ticker symbol for Advanced Biomed Inc. Common Stock, a listed security. Advanced Biomed Inc. , an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. Listed on NASDAQ. ADVB is the equity ticker shown on this page; equity options traders use the security for directional, volatility, and income strategies via the listed options chain.
- What are ADVB's key statistics?
- Advanced Biomed Inc. Common Stock (ADVB) carries a market capitalization of $5.4M, beta of 0.57 relative to the broader market, 52-week range of 3.61-21.8. Full income statement, balance sheet, cash flow, and TTM ratio history is on the per-ticker fundamentals page; daily price history and 52-week levels are accessible from the same view. These structural inputs frame how the options market prices implied volatility around earnings windows and capital events.
- What sector or industry does ADVB belong to?
- Advanced Biomed Inc. Common Stock operates in the Healthcare sector, in the Medical - Diagnostics & Research industry. Sector classification affects how the ticker correlates with sector ETFs, how it reacts to macro factors like rate moves and commodity prices, and how its options pricing compares to sector peers. Compare ADVB's implied volatility and skew against sector benchmarks to gauge whether the options market is pricing single-name or systemic risk relative to the broader peer group.
- How current is the ADVB data on this page?
- Options snapshots refresh after each trading session; if no snapshot is currently posted for ADVB, it usually reflects low options liquidity or a recently listed name. Company-profile fields (sector, industry, market cap, P/E, IPO date) refresh from the vendor feed nightly. Financials and earnings refresh as 10-K and 10-Q filings are parsed (typically within several business days of the actual report). FINRA microstructure data refreshes on the source's cadence (daily for short volume, bi-monthly for short interest, weekly for the OTC volume file, twice-monthly for SEC FTD).